Isabelle Genvresse

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher et al. · Annals of Oncology · 2016 · 229 citations · Full text

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation

Gero Massenkeil, Stefan Rackwitz, Isabelle Genvresse et al. · Bone Marrow Transplantation · 2002 · 95 citations

Cell Therapy, Transplantation, Marrow Transplantation +5

Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved

Gero Massenkeil, Marion Nagy, M Lawang et al. · Bone Marrow Transplantation · 2003 · 79 citations

Hematological Malignancy, Transplantation, Oncology +7

Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas

E. Späth‐Schwalbe, Isabelle Genvresse, A Koschuth et al. · Anti-Cancer Drugs · 2000 · 70 citations

Surgical Oncology, Phase Ii Trial, Medicine +14

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Antje Wick, Oliver Bähr, Martin Schüler et al. · Clinical Cancer Research · 2021 · 64 citations · Full text